Cleared Traditional

K952183 - DIASTAT ANTI-THYROGLOBULIN KIT

K952183 is the FDA 510(k) clearance for DIASTAT ANTI-THYROGLOBULIN KIT by Shield Diagnostics, Ltd.. It is a Class 2 Immunology device (product code JZO) cleared through the Traditional 510(k) pathway after a 52-day FDA review.

K952183 · Shield Diagnostics, Ltd. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1995
Decision
52d
Days
Class 2
Risk

K952183 is an FDA 510(k) clearance for the DIASTAT ANTI-THYROGLOBULIN KIT. Classified as System, Test, Thyroid Autoantibody (product code JZO), Class II - Special Controls.

Submitted by Shield Diagnostics, Ltd. (Dundee, GB). The FDA issued a Cleared decision on June 30, 1995 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5870 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Shield Diagnostics, Ltd. devices

Submission Details

510(k) Number K952183 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 09, 1995
Decision Date June 30, 1995
Days to Decision 52 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 104d · This submission: 52d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JZO System, Test, Thyroid Autoantibody
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5870
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - JZO System, Test, Thyroid Autoantibody

All 41
Devices cleared under the same product code (JZO) and FDA review panel - the closest regulatory comparables to K952183.
IMMULITE ANTI-TPO-AB(LKTOI,LKT05,LKTOZ
K963695 · Diagnostic Products Corp. · Jan 1997
THYROID PEROXIDASE ANTIBODY ELISA
K960369 · Immco Diagnostics, Inc. · Jun 1996
THYROGLOBULIN ANTIBODY ELISA
K960370 · Immco Diagnostics, Inc. · Jun 1996
QUANTA LITE(TM) THYROID M ELISA
K930485 · Inova Diagnostics, Inc. · Mar 1993
ELIAS TGAB
K925922 · Elias U.S.A., Inc. · Jan 1993
ELIAS TMAB
K925923 · Elias U.S.A., Inc. · Jan 1993